US 11,026,953 B2Granted

3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor

AssigneeAsarina Pharma AB

InventorsTorbjörn Bäckström, Markus Jerling

Life of this patent

Estimating the term…

Abstract

The present invention provides the steroid compound 3beta-hydroxy-5alpha-pregnan-20-one for use in treatment of essential tremor, as well as methods for treating essential tremor and pharmaceutical compositions for use in treatment of essential tremor.

Claims7

Dependent claims

A method of treating essential tremor in a patient, comprising administering an effective amount of 3beta-hydroxy-5alpha-pregnan-20-one, to the patient.

Dependencies are inferred from the claim text.

Facts

Application: 16/484,920Filed 2 Sep 2018
Priority: SE 1750124-810 Feb 2017
Published: US 2019/0381069 A119 Dec 2019
Granted: 8 Jun 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/57
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids: substituted in position 17 beta by a chain…
A61P 25/14
Drugs for disorders of the nervous system: for treating abnormal movements, e.g. chorea, dyskinesia
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K
Medicines and medical preparations

Family

US 2019/0381069 A1Pre-grant publication · published 19 Dec 2019
US 11,026,953 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results